• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《卡尔加里精神分裂症抑郁量表:法语版在精神分裂症患者群体中的效度研究》

Calgary Depression Scale for Schizophrenia: a study of the validity of a French-language version in a population of schizophrenic patients.

作者信息

Bernard D, Lançon C, Auquier P, Reine G, Addington D

机构信息

Department of Psychiatry, Sainte Marguerite Hospital, Marseille, France.

出版信息

Acta Psychiatr Scand. 1998 Jan;97(1):36-41. doi: 10.1111/j.1600-0447.1998.tb09960.x.

DOI:10.1111/j.1600-0447.1998.tb09960.x
PMID:9504701
Abstract

The Calgary Depression Scale for Schizophrenia (CDSS) is a nine-item structured interview scale developed by Addington et al. to assess depression in schizophrenics. This paper describes the testing of the reliability and validity of the French version of the CDSS in a population of 70 schizophrenic patients. The validity of the CDSS as a measure of depression was confirmed; a single factor accounted for 41% of the variance of the nine items. The total score on the CDSS was strongly correlated with those on the Montgomery-Asberg Depression Rating Scale (MADRS), the Hamilton Depression Rating Scale (HDRS) and also the G6 item (depression) of the Positive and Negative Syndrome Scale (PANSS). The correlation with the Psychomotor Retardation Scale (ERD) total score was much less significant and was better with the 'subjective' subscore. The internal consistency was good, with a Cronbach's alpha of 0.79. A high level of inter-rater reliability was observed (weighted kappa values were >0.75 in all cases). The CDSS has a lower stability over time than other depression scales. It is a simple, quick and reliable scale for assessing depression in schizophrenic populations.

摘要

《卡尔加里精神分裂症抑郁量表》(CDSS)是由阿丁顿等人编制的一个包含九个条目的结构化访谈量表,用于评估精神分裂症患者的抑郁状况。本文描述了在70名精神分裂症患者群体中对CDSS法语版的信效度测试。CDSS作为抑郁测量工具的效度得到了证实;一个单一因素解释了九个条目的41%的方差。CDSS总分与蒙哥马利-艾斯伯格抑郁评定量表(MADRS)、汉密尔顿抑郁评定量表(HDRS)以及阳性和阴性症状量表(PANSS)的G6项(抑郁)得分显著相关。与精神运动迟缓量表(ERD)总分的相关性则不太显著,与“主观”子得分的相关性更好。内部一致性良好,克朗巴哈系数为0.79。观察到评分者间信度较高(所有情况下加权kappa值均>0.75)。CDSS随时间的稳定性低于其他抑郁量表。它是评估精神分裂症群体抑郁状况的一个简单、快速且可靠的量表。

相似文献

1
Calgary Depression Scale for Schizophrenia: a study of the validity of a French-language version in a population of schizophrenic patients.《卡尔加里精神分裂症抑郁量表:法语版在精神分裂症患者群体中的效度研究》
Acta Psychiatr Scand. 1998 Jan;97(1):36-41. doi: 10.1111/j.1600-0447.1998.tb09960.x.
2
Cross-cultural adaptation and validation of the Spanish version of the Calgary Depression Scale for Schizophrenia.《卡尔加里精神分裂症抑郁量表西班牙语版的跨文化改编与验证》
Schizophr Res. 2004 Jun 1;68(2-3):349-56. doi: 10.1016/S0920-9964(02)00490-5.
3
Study of the concurrent validity of the Calgary Depression Scale for Schizophrenics (CDSS).精神分裂症患者卡尔加里抑郁量表(CDSS)的同时效度研究。
J Affect Disord. 2000 May;58(2):107-15. doi: 10.1016/s0165-0327(99)00075-0.
4
[Psychometric properties of French version of the Calgary depression scale for schizophrenics (CDSS)].[精神分裂症患者卡尔加里抑郁量表法语版(CDSS)的心理测量学特性]
Encephale. 2000 Jan-Feb;26(1):52-61.
5
The Greek version of the calgary depression scale for schizophrenia.精神分裂症卡尔加里抑郁量表希腊语版本。
Psychiatry Res. 2000 May 15;94(2):163-71. doi: 10.1016/s0165-1781(00)00137-2.
6
Evaluation of depression in schizophrenia: psychometric properties of a French version of the Calgary Depression Scale.精神分裂症中抑郁的评估:法语版卡尔加里抑郁量表的心理测量特性
Psychiatry Res. 1999 Dec 20;89(2):123-32. doi: 10.1016/s0165-1781(99)00097-9.
7
The Calgary Depression Rating Scale for Schizophrenia: development and interrater reliability of a German version (CDSS-G).用于精神分裂症的卡尔加里抑郁评定量表:德文版(CDSS-G)的编制及评分者间信度
J Psychiatr Res. 1999 Sep-Oct;33(5):433-43. doi: 10.1016/s0022-3956(99)00018-7.
8
A psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale.精神分裂症卡尔加里抑郁量表与汉密尔顿抑郁评定量表的心理测量学比较。
Schizophr Res. 1996 May;19(2-3):205-12. doi: 10.1016/0920-9964(95)00070-4.
9
Reliability and validity of a depression rating scale for schizophrenics.精神分裂症患者抑郁评定量表的信度与效度
Schizophr Res. 1992 Mar;6(3):201-8. doi: 10.1016/0920-9964(92)90003-n.
10
The Persian version of the Calgary Depression Scale for Schizophrenia (CDSS-P).《精神分裂症卡尔加里抑郁量表(CDSS-P)》的波斯语版本。
Asian J Psychiatr. 2019 Oct;45:44-49. doi: 10.1016/j.ajp.2019.08.017. Epub 2019 Aug 30.

引用本文的文献

1
PEPsy-CM study protocol: impact of a 3-year program for early psychosis based on case-management on relapse rate, a French multicenter randomized trial.PEPsy-CM研究方案:一项基于个案管理的早期精神病3年项目对复发率的影响,一项法国多中心随机试验。
BMC Psychiatry. 2025 May 15;25(1):488. doi: 10.1186/s12888-025-06940-y.
2
Impact of perceived side-effects of psychotropic treatments on quality of life in patients with severe mental illness.精神药物治疗的感知副作用对重度精神疾病患者生活质量的影响。
Dialogues Clin Neurosci. 2025 Dec;27(1):10-19. doi: 10.1080/19585969.2025.2463443. Epub 2025 Feb 11.
3
Higher stress response and altered quality of life in schizophrenia patients with low membrane levels of docosahexaenoic acid.
二十二碳六烯酸膜水平低的精神分裂症患者应激反应增强且生活质量改变。
Front Psychiatry. 2023 Feb 3;14:1089724. doi: 10.3389/fpsyt.2023.1089724. eCollection 2023.
4
Thematic analysis of the raters' experiences administering scales to assess depression and suicide in Arab schizophrenia patients.对评估阿拉伯精神分裂症患者抑郁和自杀的量表进行评估的评分者的体验进行主题分析。
BMC Psychiatry. 2022 Oct 21;22(1):652. doi: 10.1186/s12888-022-04313-3.
5
Validation of the French Clinical Assessment Interview for Negative Symptoms in a Sample of Stable French Individuals With Schizophrenia.针对一组病情稳定的法国精神分裂症患者样本,对法语版阴性症状临床评估访谈进行验证。
Front Psychiatry. 2022 Apr 1;13:836600. doi: 10.3389/fpsyt.2022.836600. eCollection 2022.
6
Immune Signatures of Treatment-Resistant Schizophrenia: A FondaMental Academic Centers of Expertise for Schizophrenia (FACE-SZ) Study.难治性精神分裂症的免疫特征:精神分裂症专业学术中心基础研究(FACE-SZ研究)
Schizophr Bull Open. 2021 Apr 27;2(1):sgab012. doi: 10.1093/schizbullopen/sgab012. eCollection 2021 Jan.
7
Depression: An actionable outcome for those at clinical high-risk.抑郁:临床高风险人群的可干预结局。
Schizophr Res. 2021 Jan;227:38-43. doi: 10.1016/j.schres.2020.10.001. Epub 2020 Oct 29.
8
Assessment of the efficacy of a fatigue management therapy in schizophrenia: study protocol for a randomized, controlled multi-centered study (ENERGY).评估疲劳管理疗法在精神分裂症中的疗效:一项随机、对照、多中心研究(ENERGY)的研究方案。
Trials. 2020 Sep 17;21(1):797. doi: 10.1186/s13063-020-04606-6.
9
The latent structure of depressive symptoms across clinical high risk and chronic phases of psychotic illness.抑郁症状在精神病临床高危期和慢性期的潜在结构。
Transl Psychiatry. 2019 Sep 16;9(1):229. doi: 10.1038/s41398-019-0563-x.
10
Tobacco smoking is associated with antipsychotic medication, physical aggressiveness, and alcohol use disorder in schizophrenia: results from the FACE-SZ national cohort.吸烟与精神分裂症中的抗精神病药物、身体侵犯和酒精使用障碍有关:来自 FACE-SZ 全国队列的研究结果。
Eur Arch Psychiatry Clin Neurosci. 2019 Jun;269(4):449-457. doi: 10.1007/s00406-018-0873-7. Epub 2018 Feb 2.